blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3840853

EP3840853 - APPLICATIONS OF KNOWN AND NOVEL CANNABINOIDS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.04.2024
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  28.05.2021
FormerThe international publication has been made
Status updated on  28.02.2020
Most recent event   Tooltip22.07.2024Change: Despatch of examination report + time limit 
Applicant(s)For all designated states
Bessor Pharma, LLC
1 Sage Lane
Framingham, MA 01701 / US
[2021/26]
Inventor(s)01 / BERKOWITZ, Barry, A.
1 Sage Lane
Framingham, MA 01701 / US
02 / BARRETT, Anthony, G.
Nossa Senhora De Copacabana 31, Apt. 606
22010121 Leme, Rio De Janeiro / BR
03 / ELLIOTT, Daniel
Davidsbodenstrasse 8
4056 Basel / CH
 [2021/26]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Postfach 13 03 91
20103 Hamburg / DE
[2021/26]
Application number, filing date19852287.220.08.2019
[2021/26]
WO2019US47284
Priority number, dateUS201862719813P20.08.2018         Original published format: US 201862719813 P
[2021/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020041326
Date:27.02.2020
Language:EN
[2020/09]
Type: A1 Application with search report 
No.:EP3840853
Date:30.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 27.02.2020 takes the place of the publication of the European patent application.
[2021/26]
Search report(s)International search report - published on:US27.02.2020
(Supplementary) European search report - dispatched on:EP28.09.2022
ClassificationIPC:A61K31/05, A61K31/352, A61P25/00
[2022/43]
CPC:
A61K31/05 (EP,KR,US); A61K31/658 (KR); C07D311/78 (US);
A61K31/352 (EP,KR,US); A61P29/00 (KR); C07C37/50 (KR,US);
C07C37/56 (US); C07C39/23 (KR,US); C07D311/80 (KR);
C07D319/08 (US); C07D493/04 (US); A61K2300/00 (KR);
C07C2601/16 (US) (-)
C-Set:
A61K31/05, A61K2300/00 (US,EP);
A61K31/352, A61K2300/00 (US,EP);
C07C37/50, C07C39/23 (US)
Former IPC [2021/26]B01D11/04, C07C37/00, C07C37/70
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/26]
TitleGerman:ANWENDUNGEN VON BEKANNTEN UND NEUARTIGEN CANNABINOIDEN[2021/26]
English:APPLICATIONS OF KNOWN AND NOVEL CANNABINOIDS[2021/26]
French:APPLICATIONS DE CANNABINOÏDES CONNUS ET NOUVEAUX[2021/26]
Entry into regional phase17.03.2021National basic fee paid 
17.03.2021Search fee paid 
17.03.2021Designation fee(s) paid 
17.03.2021Examination fee paid 
Examination procedure17.03.2021Examination requested  [2021/26]
17.04.2023Amendment by applicant (claims and/or description)
10.04.2024Despatch of a communication from the examining division (Time limit: M06)
Fees paidRenewal fee
27.08.2021Renewal fee patent year 03
29.08.2022Renewal fee patent year 04
28.08.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO0195899  (YISSUM RES DEV CO [IL], et al);
 [XI]WO2014062965  (UNIV NORTHEASTERN [US]);
 [XI]WO2015198078  (GW PHARMA LTD [GB]);
 [XI]WO2017072762  (YISSUM RES DEV CO [IL]);
 [XPI]WO2019033164  (UNIV SYDNEY [AU]);
International search[A]US8071641  (WEISS LOLA [IL], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.